100896-08-0

Usage

Uses

Used in Photochemistry:
3-(9-ANTHRYL)-L-ALANINE is used as a fluorescent probe for investigating the behavior of proteins and peptides, due to its strong fluorescence and sensitivity to its microenvironment.
Used in Biochemical Research:
3-(9-ANTHRYL)-L-ALANINE is used as a research tool for protein structure determination, helping scientists understand the three-dimensional conformation and dynamics of proteins.
Used in Pharmaceutical Research:
3-(9-ANTHRYL)-L-ALANINE is used in drug delivery systems to study molecular interactions and develop new therapeutic strategies, leveraging its unique properties to enhance the understanding of drug-protein interactions and improve drug design.
Used in the Study of Molecular Interactions:
3-(9-ANTHRYL)-L-ALANINE is employed to explore the interactions between biological molecules, providing insights into molecular recognition and binding processes, which is crucial for the development of new drugs and therapies.

Upstream product

• 24463-19-2 anthracenylmethyl chloride 
• 2584-59-0 -acetamino-malonsaeure-dimethylester 

Downstream Products

• 190319-98-3 3-Anthracen-9-yl-2-tert-butoxycarbonylamino-propionic acid 

Relevant academic research and scientific papers

Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists

Nonapeptide and decapeptide analogs of LHRH which have the formula: STR1 and the pharmaceutically acceptable salts thereof, wherein: X is a D-alanyl residue wherein one hydrogen on C-3 is replaced by:(a) a carbocyclic aryl-containing radical selected from the group consisting of phenyl substituted with three or more straight chain lower alkyl groups, naphthyl, anthryl, fluorenyl, phenanthryl, biphenylyl and benzhydryl; or(b) a saturated carbocyclic radical selected from the group consisting of cyclohexyl substituted with three or more straight chain lower alkyl groups, perhydronaphthyl, perhydrobiphenylyl, perhydro-2,2-diphenylmethyl, and adamantyl; or(c) a heterocyclic aryl containing radical selected from the group consisting of radicals represented by the following structural formulas: STR2 wherein A"" and A'' are independently selected from the group consisting of hydrogen, lower alkyl, chlorine, and bromine, and G is selected from the group consisting of oxygen, nitrogen, and sulfur;A is an aminoacyl residue selected from the group consisting of L-pyroglutamyl, D-pyroglutamyl, N-acyl-L-prolyl, N-acyl-D-prolyl, N-acyl-D-tryptophanyl, N-acyl-D-phenylalanyl, N-acyl-D-p-halophenylalanyl, and N-acyl-X wherein X is as defined previously;B is an amino acyl residue selected from the group consisting of D-phenylalanyl, D-p-halophenylalanyl, 2,2-diphenylglycyl, and X wherein X is as defined previously;C is an amino acyl residue selected from the group consisting of L-tryptophanyl, D-tryptophanyl, D-phenylalanyl and X wherein X is as defined above;E is glycinamide or --NH--R 1, wherein R 1 is lower alkyl, cycloalkyl, fluoro lower alkyl or STR3 wherein R 2 is hydrogen or lower alkyl; are disclosed. These compounds are LHRH antagonists.